Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12612001085864
Ethics application status
Approved
Date submitted
10/10/2012
Date registered
10/10/2012
Date last updated
21/01/2016
Type of registration
Prospectively registered

Titles & IDs
Public title
A vegetarian style diet versus a Western style diet on biomarkers of health and ageing in healthy volunteers
Scientific title
A pilot study investigating the effect and feasibility of a methionine restricted diet on biomarkers of health and ageing in healthy volunteers
Secondary ID [1] 281356 0
Nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Healthy volunteers 287577 0
Condition category
Condition code
Public Health 287902 287902 0 0
Health promotion/education
Diet and Nutrition 287924 287924 0 0
Other diet and nutrition disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Methionine restricted diet: As methionine content tends to be high in flesh foods, the methionine restricted diet will contain fewer meat options. The composition and energy intake of the methionine restricted diet will reflect that of the standard Western diet (~50% carbohydrate, ~15% protein and ~35% fat; 8400 KJ daily energy intake). To obtain a desirable amount of protein in the methionine restricted diet, foods that are higher in protein but lower in methionine will be chosen. For example, lentils contain roughly 25% more protein and less than half the methionine content per 100 g than beef. This study aims to restrict methionine as much as is practicable, approximately in the range of at least 40% but no more than 80% with a view to achieving 60% on average methionine restriction relative to the standard Western diet. This dietary intervention will run for 4 weeks. CSIRO will be providing a daily main meal during the intervention and guidelines for appropriate breakfast and lunch meals. There will be a 4 week washout between dietary interventions.
Intervention code [1] 285816 0
Lifestyle
Intervention code [2] 285838 0
Prevention
Comparator / control treatment
Standard Western diet: The standard Western diet is typically high in red meat, sugary desserts, high-fat foods, high-fat dairy products, sugary drinks and processed meat. In the current study, the standard Western diet will contain ~50% carbohydrate, ~15% protein and ~35% fat as is common with Western pattern diets. Energy intake will be targeted in the recommended range of 8400 KJ. This dietary intervention will run for 4 weeks. CSIRO will be providing a daily main meal during the intervention and guidelines for appropriate breakfast and lunch meals. There will be a 4 week washout between dietary interventions.
Control group
Active

Outcomes
Primary outcome [1] 288118 0
Plasma methionine measurement (blood sample assay).
Timepoint [1] 288118 0
Week 0, 2, 4, 8, 10, 12
Primary outcome [2] 288119 0
Oxidative Stress: ratio of reduced to oxidised glutathione and oxidised guanine in DNA (assay kit).
Timepoint [2] 288119 0
Week 0, 2, 4, 8, 10, 12
Primary outcome [3] 288120 0
Metabolic Stress as measured by mammalian target of rapamycin (mTOR) Activity (assay kit).
Timepoint [3] 288120 0
Week 0, 2, 4, 8, 10, 12
Secondary outcome [1] 299455 0
Serum inhibition of in vitro cancer cell culture growth as measured by Microculture Tetrazolium (MTT) assay.
Timepoint [1] 299455 0
Week 0, 2, 4, 8, 10, 12
Secondary outcome [2] 299456 0
Genome integrity of lymphocytes as determined by the cytokinesis-block micronucleus (CBMN) assay - frequency of chromosome breakage (micronuclei), chromosome loss (micronuclei), chromosome rearrangement, for example, dicentric chromosomes (nucleoplasmic bridges), gene amplification (nuclear buds), necrosis and apoptosis.
Timepoint [2] 299456 0
Week 0, 2, 4, 8, 10, 12

Eligibility
Key inclusion criteria
- Male or Female
- Aged 50-70
- Healthy with no history of cancer
- Body mass index in the healthy range (BMI): 18.5-27
Minimum age
50 Years
Maximum age
70 Years
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
- History of smoking
- Currently on medication/dietary supplements which may impact methionine, folate and B vitamin content in the blood
- Current vegetarians/vegans

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation by using a randomisation table created by computer software.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Crossover
Other design features
Phase
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/11/2012
Actual
1/11/2012
Date of last participant enrolment
Anticipated
1/11/2012
Actual
1/11/2012
Date of last data collection
Anticipated
Actual
Sample size
Target
20
Accrual to date
Final
20
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 286114 0
Self funded/Unfunded
Name [1] 286114 0
CSIRO
Country [1] 286114 0
Australia
Primary sponsor type
Government body
Name
CSIRO
Address
Gate 13 Kintore Avenue
Adelaide, SA 5000
Country
Australia
Secondary sponsor category [1] 284926 0
None
Name [1] 284926 0
Address [1] 284926 0
Country [1] 284926 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 288161 0
CSIRO Food and Nutritional Sciences Human Research Ethics Committee
Ethics committee address [1] 288161 0
Ethics committee country [1] 288161 0
Australia
Date submitted for ethics approval [1] 288161 0
Approval date [1] 288161 0
27/08/2012
Ethics approval number [1] 288161 0
12/08/2012

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 34797 0
Dr Paul Cavuoto
Address 34797 0
CSIRO
Gate 13 Kintore Avenue
Adelaide, SA 5000
Country 34797 0
Australia
Phone 34797 0
+61 8 8303 8877
Fax 34797 0
Email 34797 0
paul.cavuoto@csiro.au
Contact person for public queries
Name 18044 0
Julia Weaver
Address 18044 0
Gate 13 Kintore Avenue
Adelaide, SA 5000
Country 18044 0
Australia
Phone 18044 0
+61883038876
Fax 18044 0
Email 18044 0
julia.weaver@csiro.au
Contact person for scientific queries
Name 8972 0
Paul Cavuoto
Address 8972 0
Gate 13 Kintore Avenue
Adelaide, SA 5000
Country 8972 0
Australia
Phone 8972 0
+61883038877
Fax 8972 0
Email 8972 0
paul.cavuoto@csiro.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.